Search Results

Site Handover for Poland's First Commercial Nuclear Power Plant to Bechtel

New progress has been made in the construction of Poland's first commercial nuclear power plant. The Lubiatowo-Kopalino site in the Pomerania region of northern Poland has been handed over to Bechtel of the United States, and earthworks at the project site are underway. Polskie Elektrownie Jądrowe (PEJ), Poland's state-owned project company, stated that Bechtel has replaced PEJ as the site coordinator for the project. Under the Polish government's earlier arrangement, the nuclear power plant will feature three Westinghouse Electric Company AP1000 pressurized water reactor units. In 2023, Westinghouse Electric Company and Bechtel formed a consortium to jointly advance project implementation. The nuclear power plant is sited in the Lubiatowo-Kopalino area along the Baltic Sea coast in Poland.

2026-08-06

Hungary's Paks Nuclear Power Plant Avoids Full Shutdown as Danube Rises 2 cm, Now Operating at Only 240 MW

From the night of August 4 to the early morning of August 5, Hungary's Paks Nuclear Power Plant (about 100 km south of Budapest, commissioned in 1982, never fully shut down in its history) nearly disconnected from the grid due to low Danube water levels—3 of its 4 units had been sequentially shut down, leaving only one turbine operating at about 240 MW (normal output near 2,000 MW), supplying roughly half of Hungary's electricity. Hungarian Prime Minister Péter Magyar stated that the river level rose about 2 cm overnight, allowing the final unit's cooling to be maintained and averting the first full shutdown in 44 years; temperatures are still expected to exceed 40°C in the coming days, with cooling and rainfall only anticipated around Friday (approximately August 8). To alleviate energy pressure, Prime Minister Magyar thanked those who voluntarily...

2026-08-06

Novovoronezh NPP Unit 6 Exceeds 79 Billion kWh in a Decade of Operation

Since Unit 6 of Russia's Novovoronezh Nuclear Power Plant was first connected to the grid in 2016, it has delivered over 79 billion kWh of electricity to the Unified Energy System of Russia. The unit is the world's first Generation III+ nuclear power unit equipped with a VVER-1200 reactor, and also the first new nuclear unit built from scratch in Russia under the NPP-2006 project. The Novovoronezh NPP currently operates four units, namely Units 4, 5, 6, and 7. Unit 6 accounts for 31.2% of the plant's total electricity generation from operating units. The unit entered commercial operation in February 2017. Its construction began in 2007, with about 200 contracting organizations involved in the project. Russia...

2026-08-06

Temelín Nuclear Power Plant in Czech Republic Records Second-Highest Monthly Generation in July

Despite prevailing high temperatures, the Czech Temelín Nuclear Power Plant achieved its second-highest monthly electricity generation this year. In July, the plant delivered 1,603,637 MWh of electricity to the transmission grid, nearly matching the May record of 1,617,093 MWh. This is sufficient to cover the electricity needs of all Czech households for more than one month. Thanks to its cooling tower system, the Temelín plant was unaffected by the hot and dry weather. In contrast, some nuclear power plants abroad were forced to reduce output or even shut down due to falling river levels and rising water temperatures. However, Temelín's closed cooling cycle and its cooling towers enable it to operate independently of direct water source suppl...

2026-08-06

Oak Ridge National Laboratory Licenses Cryogenic Fuel Pellet Technology to Type One Energy

The U.S. Department of Energy's Oak Ridge National Laboratory (ORNL) has licensed a suite of cryogenic fuel pellet injection technologies to Type One Energy to advance fuel supply capabilities needed for high-performance fusion plasma operations. The two parties signed the licensing agreement on August 5 in Knoxville, Tennessee, USA. The license covers four ORNL inventions, primarily related to the design and operation of cryogenic fuel pellet injection systems. The technology forms solid hydrogen isotope fuel pellets at cryogenic temperatures near absolute zero and injects them into fusion plasma at high speeds. Compared with methods such as gas injection, pellet injection is more effective at delivering fuel deeper into the plasma...

2026-08-06

Thor Medical Commences Commercial Supply with First Delivery of High-Purity Thorium-228 from AlphaOne

Thor Medical ASA announced on August 5 that it has completed the first customer delivery of high-purity thorium-228 (Th-228) from its AlphaOne production facility at the Herøya industrial park. This marks the first customer shipment following the facility's production start announced last week, and signifies AlphaOne's entry into the commercial supply phase. Thor Medical CEO Jasper Kurth stated that commercial production represents the beginning of the company's industrial-scale manufacturing, and the first customer delivery demonstrates the company's transition from capacity building to serving customers through its first industrial-scale facility. The company stated that as production capacity gradually ramps up, it will continue to meet the growing demand for high-purity isotopes in the targeted alpha therapy field...

2026-08-06

Quantum X Labs Advances Quantum Computing for Nuclear Particle Transport Predictive Simulations

Quantum X Labs Inc. recently announced that its subsidiary, Nuclear Quantum, has proposed a new solution to a bottleneck in computational simulations for the nuclear industry, attempting to introduce quantum computing into nuclear particle transport prediction to support compute-intensive scenarios such as nuclear medicine system design. According to reports, traditional particle transport simulations play an important role in nuclear medicine system design, but they often require substantial computational resources and involve long runtimes, impacting R&D and optimization efficiency. The technology proposed by Nuclear Quantum aims to transform physical transport models into quantum circuits, enabling particle propagation and random walk dynamics to be directly represented and simulated within a quantum computing framework...

2026-08-06

Leonardo DRS to Build New Facility in Connecticut, U.S. to Support Growth in Naval Nuclear Propulsion-Related Business

Leonardo DRS announced on August 4 that it has signed an agreement to build a new facility in Brookfield, Connecticut, U.S., to expand and consolidate its naval electric power systems operations. The project aims to increase production capacity, support key U.S. Navy-related programs, and provide space and infrastructure for the company's future growth in the nuclear energy sector. According to the company's disclosure, the new facility is located at 120 Park Ridge Road in Brookfield, covering approximately 141,087 square feet. Once completed, the facility will consolidate operations currently spread across three locations in Danbury and Bethel, Connecticut. The facility is expected to be operational in early 2027, with partial occupancy potentially available by late 2026 if final design and tenant fit-out work proceed smoothly.

2026-08-06

First American Nuclear Company (FANCO) Receives DOE Funding to Accelerate Advanced Nuclear Reactor Development

First American Nuclear Company (FANCO) has received two Rapid Turnaround Experiment (RTE) awards from the U.S. Department of Energy's Office of Nuclear Energy, enabling the company to leverage specialized national laboratory research capabilities to support the development of its EAGL-1 small modular reactor. These awards were granted during the FY2026 RTE selection cycle, which evaluates proposals based on technical superiority, feasibility, and relevance to DOE's nuclear energy programs. The program provides researchers with free access to radiation testing, post-irradiation examination facilities, and technical expertise. FANCO-approved research projects include a study on the effects of extrusion temperature on FeCrAl-ODS alloys in liquid metal fast...

2026-08-06

Nuclea to Explore Building Nuclear Test Reactor in Utah to Advance Morpheus Microreactor Deployment

On August 5, Mangoceuticals announced that Nuclea Energy USA Inc., a wholly owned subsidiary of its merger partner, has signed a memorandum of understanding with the Utah Office of Energy Development to explore siting a nuclear test reactor at the Utah St. Rafael Energy Laboratory to advance the deployment of the Morpheus microreactor. Under the MOU, Nuclea USA and the Utah Office of Energy Development will collaborate on test reactor siting and support related communications and coordination with the U.S. Department of Energy and the U.S. Nuclear Regulatory Commission. The parties will also evaluate pathways for future deployment of Nuclea's technology in Utah. The collaboration is seen as a step in Nuclea's micro modular react...

2026-08-06

University of Toronto joins Canadian Nuclear Laboratories academic partnership program

The University of Toronto (U of T) has joined Canadian Nuclear Laboratories' (CNL) academic partnership program, becoming the tenth participating institution in the initiative. This effort aims to strengthen Canada's nuclear talent pipeline and support related research. A signing ceremony was held at the Schwartz Reisman Innovation Campus, marking the formal establishment of the partnership between the University of Toronto, Canadian Nuclear Laboratories, and Atomic Energy of Canada Limited (AECL). The academic partnership program will provide participating institutions with access to national laboratory infrastructure, technology, and expertise, with collaboration areas spanning clean energy, health care, environmental remediation, and national security, among others. This...

2026-08-06

Terra Innovatum Selected for Global X Uranium ETF Tracking Nuclear Index, Microreactor SOLO™ Gains Passive Fund Exposure

Terra Innovatum Global N.V. (NASDAQ: NKLR), a Netherlands-registered micro modular reactor developer, will be included in the Solactive Global Uranium & Nuclear Components Total Return Index effective from the market open on August 3, 2026 — the benchmark tracked by the Global X Uranium ETF (NYSE Arca: URA, with over $5 billion in assets under management), taking effect with Solactive's periodic rebalancing. Co-founder and CEO Alessandro Petruzzi stated that this enables passive/thematic investors to directly access its SOLO™ microreactor story through the index, alongside Cameco, Kazatomprom, Centrus, Oklo, NuScale, X-energy, Mitsubishi Heavy Industries, and others in the nuclear fuel cycle and reactor development tier.

2026-08-06

Two Advanced Materials Research Projects by 1st American Nuclear Co. Supported by U.S. Department of Energy Nuclear Science User Facilities Program

1st American Nuclear Co. (FANCO) announced on August 3 that two research proposals submitted by its scientists have been selected for support under the Nuclear Science User Facilities (NSUF) program of the U.S. Department of Energy Office of Nuclear Energy. Both selected projects come from the NSUF Fiscal Year 2026 Rapid Turnaround Experiment (RTE) review cycle, with research focused on next-generation reactor materials and fuel-related issues. The NSUF Rapid Turnaround Experiment program is open to nuclear energy researchers and primarily provides irradiation testing, post-irradiation examination capabilities, and related technical support...

2026-08-06

South Korea advances plan to produce medical isotopes using nuclear power plants, with lutetium-177 targeted for commercial production in 2031

South Korea is advancing plans to industrialize the production of radioisotopes using nuclear power plants, with the medical isotope lutetium-177 (Lu-177) designated as the first commercial target product. Korea Hydro & Nuclear Power stated that it plans to prioritize the commercialization of Lu-177 production, with the potential to later expand the product range to include isotopes such as cobalt-60, tritium-3, and helium-3. Lu-177 is a therapeutic radioisotope widely used in the global radiopharmaceutical market, applicable in radiopharmaceuticals for diseases such as prostate cancer and neuroendocrine tumors. Previously, South Korea relied entirely on imports for its Lu-177 supply. Due to its half-life of approximately 6.6 days, the entire process from production and transportation to drug preparation and patient administration...

2026-08-06

Japan's Plutonium Stockpile Expected to Remain at 44.4 Tons by End of 2025

Japan's Cabinet Office reported to the Japan Atomic Energy Commission (JAEC) on August 5 that Japan's plutonium stockpile is expected to be 44.4 tons by the end of 2025, unchanged from the end of the previous year. By source, domestically sourced plutonium stockpile is expected to be 9.9 tons, while overseas-sourced plutonium stockpile is 34.5 tons. The overseas-sourced plutonium mainly comes from separated plutonium formed after Japan entrusted its spent fuel reprocessing operations to the United Kingdom and France. The report shows that in 2024, Kansai Electric Power Company (KEPCO) processed 1.3 tons of plutonium stored in France into mixed uranium-plutonium oxide fuel, namely MOX fuel, resulting in a decrease in overseas-sourced plutonium stockpile. Subsequently, this batch of MOX fuel was shipped to the Takahama Nuclear Power...

2026-08-06